Can zapping all tumors slow prostate cancer? major trial seeks answers.
NCT ID NCT03784755
First seen Nov 20, 2025 · Last updated Apr 25, 2026 · Updated 27 times
Summary
This study tests whether adding targeted radiation or surgery to all visible cancer spots (up to 5) improves outcomes for men with prostate cancer that has spread to a few places. About 400 men with hormone-sensitive prostate cancer are randomly assigned to get either standard hormone therapy alone or standard therapy plus local ablative treatment. The goal is to see if this aggressive approach delays cancer progression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Algoma District Cancer Program
Sault Ste. Marie, Ontario, P6B 0A8, Canada
-
Allan Blair Cancer Centre
Regina, Saskatchewan, S4T 7T1, Canada
-
BCCA - Victoria
Victoria, British Columbia, V8R 6V5, Canada
-
CHUM-Centre Hospitalier de l'Universite de Montreal
Montreal, Quebec, H2X 3E4, Canada
-
CIUSSS de l'Est-de-I'lle-de-Montreal
Montreal, Quebec, H1T 2M4, Canada
-
CancerCare Manitoba
Winnipeg, Manitoba, R3E 0V9, Canada
-
Health Sciences North
Greater Sudbury, Ontario, P3E 5J1, Canada
-
Hotel-Dieu de Quebec
Québec, Quebec, G1R 2J6, Canada
-
Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, L8V 5C2, Canada
-
Kingston Health Sciences Centre
Kingston, Ontario, K7L 2V7, Canada
-
Odette Cancer Centre
Toronto, Ontario, M4N 3M5, Canada
-
Ottawa Hospital Research Institute
Ottawa, Ontario, K1H 8L6, Canada
-
QEII Health Sciences Centre
Halifax, Nova Scotia, B3H 1V7, Canada
-
Royal Victoria Regional Health Centre
Barrie, Ontario, L4M 6M2, Canada
-
Saskatoon Cancer Centre
Saskatoon, Saskatchewan, S7N 4H4, Canada
-
The Jewish General Hospital
Montreal, Quebec, H3T 1E2, Canada
-
Trillium Health Partners - Credit Valley Hospital
Mississauga, Ontario, L5M 2N1, Canada
-
University Health Network
Toronto, Ontario, M5G 2M9, Canada
Conditions
Explore the condition pages connected to this study.